Sign in
TECX Stock Price, Chart, Stats & News
Tectonic Therapeutic, Inc.
Save
Tectonic Therapeutic, Inc. (TECX) does not currently pay a dividend.
427.99M
Market cap
–
Current P/E
–
Forward P/E
TECX chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | -1.69% |
ROA | -28.41% |
ROE | -26.87% |
D/E | 0.01x |
Interest coverage ratio | -1333.90x |
TECX valuation
P/E | – |
P/S | – |
P/B | 2.14x |
P/CF | -8.95x |
P/FCF | -9.13x |
P/OCF | -8.95x |
PEG | 1.47x |
EV multiple | -11.24x |
About
Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the discovery and development of these GPCR-targeted medicines. Its robust pipeline includes an RXFP1 agonist, currently undergoing Phase 1a and 1b clinical trials for the treatment of heart failure with preserved ejection fraction.
Similar securities
Based on sector and market capitalization
Report issue